Adial Pharmaceuticals News

EXCLUSIVE: Adial Pharmaceuticals' Lead Drug Secures Key US Patent For Alcohol Dependence Based on Expanded Genotype Combinations

BenzingaDec 3 08:00 ET

Express News | EXCLUSIVE: Adial Pharmaceuticals Tells Benzinga Co. Granted Key U.S. Patent For The Treatment Of Alcohol And Drug Dependence Based On Expanded Genotype Combinations

BenzingaDec 3 08:00 ET

Adial Pharmaceuticals (ADIL) Upgraded to Buy: Here's What You Should Know

Yahoo FinanceNov 25 12:00 ET

Maxim Group Maintains Adial Pharmaceuticals(ADIL.US) With Hold Rating

Moomoo NewsNov 15 16:32 ET · Ratings

Maxim Group Sticks to Their Hold Rating for Adial Pharmaceuticals (ADIL)

TipRanksNov 15 15:35 ET

12 Health Care Stocks Moving In Thursday's Pre-Market Session

BenzingaNov 14 16:10 ET

Express News | Adial Pharmaceuticals : Continued Excellent Safety & Tolerability Findings, Consistent With Extensive Human Use Experience With Ondansetron

ReutersNov 14 08:32 ET

Express News | Adial Pharmaceuticals Inc - Study Completion Satisfies FDA Requirement for Phase 3 Trials

ReutersNov 14 08:30 ET

Adial Pharmaceuticals Announces Positive Topline Results From the AD04-103 Pharmacokinetics Study of AD04 for the Treatment of Alcohol Use Disorder

GlobeNewswireNov 14 08:30 ET

EXCLUSIVE: Adial Pharmaceuticals Reveals Topline Results From Pharmacokinetics Study Of AD04 For Alcohol Use Disorder

BenzingaNov 14 08:00 ET

Express News | EXCLUSIVE: Adial Pharmaceuticals Tells Benzinga 'Marks Final Study Needed for the Upcoming FDA Meeting for the Phase 3 Study Design and Ongoing Partnership Discussions'

BenzingaNov 14 08:00 ET

Express News | EXCLUSIVE: Adial Pharmaceuticals Tells Benzinga 'Confirmed Relative Bioavailability to the Reference Standard, Dose Proportional Increases in Pharmacokinetic Exposure, and No Food Effect'

BenzingaNov 14 08:00 ET

Express News | EXCLUSIVE: Adial Pharmaceuticals Tells Benzinga Co. Announces Results From AD04-103 Pharmacokinetics Study Of AD04 For The Treatment Of Alcohol USE Disorder

BenzingaNov 14 08:00 ET

This Turning Point Brands Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Thursday

BenzingaNov 14 07:53 ET

Adial Pharmaceuticals Analyst Ratings

BenzingaNov 14 06:51 ET · Ratings

Adial Pharmaceuticals Initiated With a Buy at Rodman & Renshaw

TipRanksNov 14 06:46 ET · Ratings

10-Q: Q3 2024 Earnings Report

SECNov 13 16:47 ET · Announcements

Adial Pharmaceuticals Expects Cash to Fund Operations Into Second Half of 2025

TipRanksNov 13 08:36 ET

Express News | Adial Pharmaceuticals Reports Third Quarter 2024 Financial Results and Provides Business Update

ReutersNov 13 08:30 ET

Adial Pharmaceuticals Approves Strategic Changes at Annual Meeting

TipRanksNov 12 16:46 ET